These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 2444713)

  • 1. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
    Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC
    J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.
    Highlander SL; Cai WH; Person S; Levine M; Glorioso JC
    J Virol; 1988 Jun; 62(6):1881-8. PubMed ID: 2452895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion.
    Navarro D; Paz P; Pereira L
    Virology; 1992 Jan; 186(1):99-112. PubMed ID: 1370130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration.
    Highlander SL; Dorney DJ; Gage PJ; Holland TC; Cai W; Person S; Levine M; Glorioso JC
    J Virol; 1989 Feb; 63(2):730-8. PubMed ID: 2463380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.
    Marlin SD; Highlander SL; Holland TC; Levine M; Glorioso JC
    J Virol; 1986 Jul; 59(1):142-53. PubMed ID: 2423702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
    Holland TC; Marlin SD; Levine M; Glorioso J
    J Virol; 1983 Feb; 45(2):672-82. PubMed ID: 6187935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.
    Marlin SD; Holland TC; Levine M; Glorioso JC
    J Virol; 1985 Jan; 53(1):128-36. PubMed ID: 2578193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies.
    Fuller AO; Spear PG
    J Virol; 1985 Aug; 55(2):475-82. PubMed ID: 2991570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G; Kaerner HC; Levine M; Schröder CH; Glorioso JC
    J Virol; 1985 Dec; 56(3):930-7. PubMed ID: 2415719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants.
    Muggeridge MI; Isola VJ; Byrn RA; Tucker TJ; Minson AC; Glorioso JC; Cohen GH; Eisenberg RJ
    J Virol; 1988 Sep; 62(9):3274-80. PubMed ID: 2841479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D.
    Muggeridge MI; Wu TT; Johnson DC; Glorioso JC; Eisenberg RJ; Cohen GH
    Virology; 1990 Feb; 174(2):375-87. PubMed ID: 2154881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivity.
    Muggeridge MI; Wilcox WC; Cohen GH; Eisenberg RJ
    J Virol; 1990 Aug; 64(8):3617-26. PubMed ID: 1695252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization.
    Minson AC; Hodgman TC; Digard P; Hancock DC; Bell SE; Buckmaster EA
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1001-13. PubMed ID: 2423636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.
    Atanasiu D; Saw WT; Lazear E; Whitbeck JC; Cairns TM; Lou H; Eisenberg RJ; Cohen GH
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H.
    Gompels UA; Carss AL; Saxby C; Hancock DC; Forrester A; Minson AC
    J Virol; 1991 May; 65(5):2393-401. PubMed ID: 1707982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratypic variations in neutralizable epitopes among herpes simplex virus type 2 isolates.
    Bhattarakosol P; Yoosook C; Matangkasombut P
    Microbiol Immunol; 1991; 35(7):525-33. PubMed ID: 1723784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
    Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus.
    Campadelli-Fiume G; Qi S; Avitabile E; Foà-Tomasi L; Brandimarti R; Roizman B
    J Virol; 1990 Dec; 64(12):6070-9. PubMed ID: 2173780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.